UBR5 and esophageal cancer: A previous study had reported that AKT phosphorylates SOX2 at T116 and blocks the interaction of SOX2 with UBR5, which protects SOX2 from ubiquitin-dependent protein degradation by UBR5 in human esophageal cancer (Fig. 4a).